Laura Ungar and Samantha Young
Kaiser Health News
California mom Megan Bacigalupi has had enough. She wants her kindergartner and second-grader back in their Oakland classrooms.
But the coronavirus is spreading too quickly to open schools in Alameda County, based on current state standards. And the local teachers union hasn’t agreed to go back – even after teachers have been vaccinated. So she expects her kids will be logging on to school from home for a while.
“The impediments to opening are just too great,” said Bacigalupi, who is lobbying California lawmakers to establish firm, statewide health metrics that, once met, would require schools to open. “In the end, it comes down to a lack of political will to get the kids back in the classroom.”
Posted on 528
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that two abstracts featuring data from clinical studies evaluating Rubraca® (rucaparib) in metastatic castration-resistant prostate cancer (mCRPC) and one abstract describing adverse events associated with mCRPC treatment based on real world evidence have been accepted for poster presentation at the American Society of Clinical Oncology (ASCO) 2021 Genitourinary Cancers Symposium to be held virtually, February 11-13, 2021.
“These data underscore our continued commitment to fully understanding the clinical role of Rubraca and to accelerating the delivery of transformative therapies to the advanced prostate cancer community,” said Patrick J. Mahaffy, President and CEO of Clovis Oncology. “The data that will be shared add to growing scientific knowledge about the science of mCRPC and broaden our understanding of Rubraca as a treatment option for pati
Newly launched medical truck brings the emergency room to cardiac arrest patients
University of Minnesota, The Leona M. and Harry B. Helmsley Charitable Trust and health care system partners announce the launch of a truck outfitted with medical equipment and virtual reality technology to help experts attend to patients remotely for extracorporeal membrane oxygenation (ECMO). Part of the Minnesota Mobile Resuscitation Consortium (MMRC), the truck brings the emergency room to cardiac arrest patients and is an innovative step in providing care to cardiac arrest patients who need to be placed on ECMO.
This approach will allow experts to administer treatment on-site in the vehicle shortening the time to treatment and broadening the area served by MMRC. Every 10-minute delay in treatment for these patients increases the chances of mortality by 15 to 25%. This technology and community partnership aims to save the lives of cardiac arrest patients in scenarios which traditional resuscitat
Increased Accuracy of CMV Detection in Newborn Screening by Angela Mohan on February 3, 2021 at 3:15 PM
Improved techniques were identified to show that the dried blood spot taken at birth can find CMV infection in the newborn with almost 90% accuracy, according to the study published in
JAMA Pediatrics by Mark Schleiss, MD, pediatric infectious disease physician with the University of Minnesota Medical School and M Health Fairview.
In Minnesota, there are currently about 60 diseases that all newborns are screened for at birth using a heel prick and a few drops of blood. Of all the screenable disorders combined, newborn infection with cytomegalovirus (CMV) is most common, and it is ranked as the most prevalent infectious disease in the U.S. and Europe that causes birth defects, long-term disabilities and deafness in babies.
Written by Ashley Welch on February 2, 2021 Fact checked by Dana K. Cassell
Vaccine-hesitant groups are exploiting the deaths of people who died of old age or underlying health conditions after receiving the COVID-19 shot to undermine trust in the vaccines. Westend61/Getty Images
Scientists say some deaths will occur during the COVID-19 vaccination rollout, but these deaths would have happened for other reasons and are unrelated to the vaccine.
The newness of the virus and uncertainty about COVID-19 make people more susceptible to misinformation, experts say.
People can implement strategies, including research and corroboration, to ensure the information they’re reading about the COVID-19 vaccines is credible.